ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Astrazeneca Plc

Astrazeneca Plc is an active company incorporated on 17 June 1992 with the registered office located in Cambridge, Cambridgeshire. Astrazeneca Plc was registered 33 years ago.
Status
Active
Active since incorporation
Company No
02723534
Public limited company
Age
33 years
Incorporated 17 June 1992
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Over 250 employees
Confirmation
Submitted
Dated 15 May 2025 (3 months ago)
Next confirmation dated 15 May 2026
Due by 29 May 2026 (8 months remaining)
Last change occurred 3 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (9 months remaining)
Contact
Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA
United Kingdom
Address changed on 23 Aug 2023 (2 years ago)
Previous address was
Telephone
01625582828
Email
Unreported
People
Officers
18
Shareholders
1
Controllers (PSC)
-
Director • Belgian,swiss • Lives in Switzerland • Born in Aug 1956
Director • Board Director • American • Lives in United States • Born in Feb 1960
Director • Non-Executive Director • American • Lives in United States • Born in Oct 1958
Director • Swedish • Born in Sep 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Astrazeneca UK Limited
Adrian Charles Noel Kemp, Pascal Claude Roland Soriot, and 1 more are mutual people.
Active
Medimmune Limited
Adrian Charles Noel Kemp and Aradhana Sarin are mutual people.
Active
Kudos Pharmaceuticals Limited
Adrian Charles Noel Kemp and Aradhana Sarin are mutual people.
Active
Astrazeneca Intermediate Holdings Limited
Adrian Charles Noel Kemp and Aradhana Sarin are mutual people.
Active
Astra Pharmaceuticals Limited
Adrian Charles Noel Kemp is a mutual person.
Active
Astrapharm
Adrian Charles Noel Kemp is a mutual person.
Active
British Pharma Group Limited
Pascal Claude Roland Soriot is a mutual person.
Active
Astrazeneca Nominees Limited
Adrian Charles Noel Kemp is a mutual person.
Active
Brands
AstraZeneca
AstraZeneca is a research-based bio-pharmaceutical company that focuses on the discovery, development, and commercialization of medicines..
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£4.38B
Decreased by £201M (-4%)
Turnover
£43.19B
Increased by £7.23B (+20%)
Employees
92.9K
Increased by 6.5K (+8%)
Total Assets
£83.09B
Increased by £3.72B (+5%)
Total Liabilities
-£50.52B
Increased by £1.87B (+4%)
Net Assets
£32.57B
Increased by £1.85B (+6%)
Debt Ratio (%)
61%
Decreased by 0.49% (-1%)
Latest Activity
Confirmation Submitted
3 Months Ago on 28 May 2025
Matthew Shaun Bowden Appointed
4 Months Ago on 1 May 2025
Adrian Charles Noel Kemp Resigned
4 Months Ago on 1 May 2025
Group Accounts Submitted
4 Months Ago on 23 Apr 2025
Karen Elizabeth Knudsen Costello Appointed
4 Months Ago on 11 Apr 2025
Andreas Rummelt Resigned
4 Months Ago on 11 Apr 2025
Deborah Disanzo Eldracher Resigned
4 Months Ago on 11 Apr 2025
Birgit Conix Appointed
7 Months Ago on 1 Feb 2025
Rene Anthony Andrada Haas Appointed
8 Months Ago on 1 Jan 2025
Aradhana Sarin Details Changed
1 Year Ago on 22 Aug 2024
Get Credit Report
Discover Astrazeneca Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 28 August 2025
Submitted on 2 Sep 2025
Statement of capital following an allotment of shares on 23 July 2025
Submitted on 29 Jul 2025
Statement of capital following an allotment of shares on 14 May 2025
Submitted on 23 Jul 2025
Statement of capital following an allotment of shares on 18 June 2025
Submitted on 11 Jul 2025
Second filed SH01 - 25/04/25 Statement of Capital usd 387659483 25/04/25 Statement of Capital gbp 50000
Submitted on 28 May 2025
Confirmation statement made on 15 May 2025 with updates
Submitted on 28 May 2025
Statement of capital following an allotment of shares on 2 April 2025
Submitted on 8 May 2025
Appointment of Matthew Shaun Bowden as a secretary on 1 May 2025
Submitted on 2 May 2025
Termination of appointment of Adrian Charles Noel Kemp as a secretary on 1 May 2025
Submitted on 1 May 2025
Resolutions
Submitted on 25 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year